initial public offerings (IPOs) trading on American exchanges

Friday, August 16, 2024

Tango Therapeutics (TNGX) : 3-year performance

  • IPO: Tango went public via merger with BCTG Acquisition Corp. (BCTG), a special purpose acquisition company (SPAC), on August 11, 2021.
  • ticker : TNGX

 
 
 
 
  • 5 weeks later 



About Tango Therapeutics
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

No comments:

Post a Comment